These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27189130)

  • 1. Venous thrombosis.
    Wolberg AS; Rosendaal FR; Weitz JI; Jaffer IH; Agnelli G; Baglin T; Mackman N
    Nat Rev Dis Primers; 2015 May; 1():15006. PubMed ID: 27189130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic complications of venous thromboembolism.
    Winter MP; Schernthaner GH; Lang IM
    J Thromb Haemost; 2017 Aug; 15(8):1531-1540. PubMed ID: 28762624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep venous thrombosis.
    López JA; Kearon C; Lee AY
    Hematology Am Soc Hematol Educ Program; 2004; ():439-56. PubMed ID: 15561697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation.
    Prandoni P; Lensing AW; Prins MH; Pesavento R; Piccioli A; Sartori MT; Tormene D; Milan M; Vedovetto V; Noventa F; Villalta S; Harenberg J
    Semin Thromb Hemost; 2015 Mar; 41(2):133-40. PubMed ID: 25682083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism: New Concepts in Perioperative Management.
    Elisha S; Heiner J; Nagelhout J; Gabot M
    AANA J; 2015 Jun; 83(3):211-21. PubMed ID: 26137764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of venous thromboembolism.
    Burnett B
    Prim Care; 2013 Mar; 40(1):73-90. PubMed ID: 23402462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antithrombotic strategies for treatment of venous thromboembolism.
    Weitz JI; Chan NC
    Blood; 2020 Jan; 135(5):351-359. PubMed ID: 31917385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
    Gilmore R; Doyle M; Holden F; White B; O'Donnell J
    Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications of medical patients with hospital-acquired venous thromboembolism.
    Fanikos J; Piazza G; Zayaruzny M; Goldhaber SZ
    Thromb Haemost; 2009 Oct; 102(4):688-93. PubMed ID: 19806254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
    J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism: epidemiology and magnitude of the problem.
    Goldhaber SZ
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):235-42. PubMed ID: 22959540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in venous thromboembolism--2015.
    Keeling D; Klok FA; Le Gal G
    Blood Rev; 2016 Jan; 30(1):27-33. PubMed ID: 26239706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in pregnancy.
    James AH
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [News in the work-up of deep vein thrombosis (DVT)].
    Wautrecht JC
    Rev Med Brux; 2015 Sep; 36(4):327-32. PubMed ID: 26591320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.